The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this approach offers a less invasive way to provide GLP-1 https://marleyixzp135425.laowaiblog.com/39644780/glp-1-patches-a-novel-approach-to-glucose-control